Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

MediTrack Project - Track & Trace System for Pharmaceuticals


Announcement of Training Courses on the MediTrack System 

In implementation of Resolution No. 988/1 issued on August 21, 2023, the Ministry of Public Health is organizing training courses on the MediTrack drug tracking system for all pharmacies licensed by the Ministry of Public Health, according to the geographical distribution of these pharmacies.

The training courses will take place online via "Zoom".

Therefore, all pharmacists who own licensed pharmacies wishing to train are required to submit an application via the following url :  https://forms.gle/fhtgp5L9dBCxS1W6A

The World Health Organization will distribute the 2D Barcode Readers to all pharmacies that participated in the training.

We hope that everyone will cooperate and coordinate with the Ministry of Public Health and the e-Health Program to implement this system to control the process of dispensing medications and to ensure the safe delivery of medication to the patient.

For review and inquiries, please contact the e-Health Program via:
Email: ehealth@moph.gov.lb 
Phone: 01-830268 or 01-830292
 
 
Project Definition
Strategic Framework
 
  • This project comes within the plan to reform and develop the pharmaceutical sector in Lebanon by reviewing legislation, regulating the process of drug registration and pricing, and formulating quality assurance standards and programs with the aim of providing safe and quality-assured medicine at the right price for the patient.
  • The E-Health Program team at the Ministry of Public Health implements and manages this project under the leadership of the Program Director, Mrs. Lina Abu Mrad, and in coordination with the Pharmacy Department and its affiliated departments and the IT Department, and in cooperation with all concerned authorities and stakeholders in the health sector.
  • This project is being implemented with the support and funding of the World Health Organization, the Italian government, and the European Union, where the necessary hardware and equipment are provided, including servers, computers and barcode readers.

Project Goals and Importance
  • Ensuring safe drug access to the patient.
  • Controlling the dispensing of subsidized medicines.
  • Preventing medicines storage.
  • Visibility and Protection from the point of manufacture to sale to the consumer.
  • Production process compliant with regulations.
  • Reducing counterfeited and illegal drugs.
  • Fast recalls from the market.
  • Fast Reimbursement and fraud control at the third party payers
 
 
Project Summary
 
  • Work has begun on this project in the Ministry of Public Health since 2017, several regulatory decisions have been issued with the aim of implementing the 2D Matrix Barcode on all medicines registered or intended to be registered at the Ministry of Public Health by all pharmaceutical institutions and pharmaceutical factories duly registered in the Ministry of Public Health and which intends to manufacture or import medicines.
 
  • Barcode Structure
The two-dimensional barcode is compliant with international standards issued by the Global Standard Organization (GS1) and contains the below information:
 
AI Description Numbers
GTIN 1
Batch or Lot # 10
Expiry Date 17
The manufacturer prints the two-dimensional barcode on the outer packaging of the drug.
  • In 2017, the Ministry of Public Health developed an information system to track and trace the medicines (MediTrack) within the supply chain from manufacturing, to storage, distribution and dispensing to patients through a unified drug identification number (2D Matrix barcode).
  • The pilot phase of MediTrack began in March 2018, in which about 19 pharmaceutical institutions participated, till the end of 2018, as per the ministerial decision No. 2428 dated 12/14/2017.
  • In 2020, the Lebanese Ministry of Public Health issues guidelines, according to the international guidelines of the GS1, and stresses the importance of adhering to this manual by all parties involved, as relevant to the particular role that they play, believing that the barcoding technology adds an extra level of patient safety to the medication administration process.
  • At the end of 2020, the MediTrack system was implemented with drug warehouse owners in Lebanon, and all importers and distributors of medicines in Lebanon were connected to the information system to track the movement of imported medicines.
  • In the summer of 2022, the decrease in the budget allocated by the Central Bank of Lebanon for total subsidies for catastrophic illnesses led to an urgent need to track the dispensing of subsidized medicines up to the patient level in both the public and private sectors. The Ministry of Public Health took this opportunity to accelerate the implementation of the MediTrack system in hospitals and pharmacies as a way to control the sale of subsidized cancer medicines and to prevent the storage of medicines or their transfer to foreign markets.
  • Since August 2022, pharmaceutical institutions (hospitals, pharmacies, pharmaceutical factories, importers, distributors, security forces, donors, non-governmental organizations and health care centers...) have been trained and connected to the MediTrack system because the dispensing of some cancer drugs and other subsidized drugs must be done exclusively on the MediTrack system as per Minister Decision No. 6/1 issued on 5/1/2023.  The patient must be registered in a center identified by MoPH to have a Unique Health ID as a condition for obtaining the treatment.
  • Since the beginning of this year 2023, the national pharmaceutical manufacturers have also started working on applying and printing two-dimensional barcodes on all locally manufactured medicines. They have also been trained on MediTrack system and they started working on it. Thus, all medicines in the Lebanese markets are now tracked within the supply chain.
  • From 2017, several decisions and regulatory documents (more than 30) have been issued to keep pace with the implementation and development of this project.
  • Coordination is made on a permanent basis with the Department of Pharmacy in legislative matters, especially with regard to pharmaceutical institutions and the organization of the drugs registration and pricing process. Coordination is also made with the Pharmacy Inspection Department in terms of checking and validating the information of imported drugs and their invoices entered on MediTrack by importers in order to to approve their distribution.
  • Cooperation is also taking place with the IT Department regarding the implementation of the “Unique Health ID” platform and training of registration centers identified by MoPH to use this platform to register patients and provide them with their Unique ID in order to have access to treatment.   
 
Information Flow

 
Administrative Procedures for Patient's Access to Drugs through Meditrack
 
للحصول على الدواء
 
مريض السرطان:
  1.  الحصول على رقم صحي موحد
  2. التواصل مع طبيبك المختص لتعبئة ملف خاص بك على منصة امان
  3. انتظار رسالة نصية من وزارة الصحه تبلغ المريض اذا كان ( مقبول، مرفوض، قيد الدرس ) بحالة القبول عليه المتابعه مع المستشفى اذا كان الدواء يعطى من خلال الوريد، في حال كان الدواء يعطى على شكل حبوب / حقن سيتم التواصل مع المريض من خلال فريق عمل وزارة الصحه خلال مهلة اسبوع لمعرفة الصيدليه القريبه من السكن و ارسال الدواء اليه من ثم يتابع المريض بعدها مع الصيدليه شهريا . 
مريض التصلب اللويحي :
  1. الحصول على رقم صحي موحد
  2. التواصل مع طبيبك المختص لتعبئة ملف خاص بك على منصة امان
  3. انتظار رسالة نصية من وزارة الصحه تبلغ المريض اذا كان ( مقبول، مرفوض، قيد الدرس ) بحالة القبول عليه المتابعه مع المستشفى اذا كان الدواء يعطى من خلال الوريد، في حال كان الدواء يعطى على شكل حبوب / حقن سيتم التواصل مع المريض من خلال فريق عمل وزارة الصحه خلال مهلة اسبوع لمعرفة الصيدليه القريبه من السكن و ارسال الدواء اليه من ثم يتابع المريض بعدها مع الصيدليه شهريا. 
مريض الهيمو فيليا :
  1. الحصول على رقم صحي موحد 
  2. التواصل مع طبيبك المختص لتعبئة ملفك الصحي على  منصة امان
  3. أو تقديم المستندات التالية إلى وزارة الصحة العامة او اقرب مركز لها أو ارسالها عبر رسالة واتساب على الرقم التالي  81/348838
المستندات المطلوبه هي :
صورة عن الهوية، رقم صحي موحد، تقرير طبي مفصل  (مع ذكر الدواء والعيار والجرعة اليومية)، وصفة طبية موحدة.
تقوم الشركة بتسليم الدواء للصيدلية المحددة او عبر الكرنتينا اذا كان المريض غير مضمون او عبر مراكز الدواء الموزعه بالمراكز.
تستغرق هذه العملية تقريبا ٥ ايام عمل بدء من وقت تسليم المستندات المتعلقة بالمريض لجانب وزارة الصحة العامة

مرضى التلاسيميا :
  1.  الحصول على رقم صحي موحد 
  2. التواصل مع طبيبك المختص لتعبئة ملفك الصحي على  منصة امان
  3. أو تقديم المستندات التالية إلى وزارة الصحة العامة او اقرب مركز لها أو ارسالها عبر رسالة واتساب على الرقم التالي  81/348838
المستندات المطلوبه هي :
صورة عن الهوية، رقم صحي موحد، تقرير طبي مفصل  (مع ذكر الدواء والعيار والجرعة اليومية)، وصفة طبية موحدة.
 
مرضى الزرع: دواء Advagraf or Prograf
  1. الحصول على رقم صحي موحد 
  2. التواصل مع طبيبك المختص لتعبئة ملفك الصحي على  منصة امان
  3. او اعطاء وزارة الصحه المستندات التاليه :
 
  • تقرير طبي جديد  (تقرير طبي جديد  يقدم لمرة واحدة يبين ان المريض اجريت له عملية زراعة عضو وهو بحاجة لهذا الدواء مدى الحياة) .
  • رقم صحي موحدد
  • وصفة طبية جديدة لا تقل عن شهر  ( مع ذكر الدواء والعيار والجرعة اليومية) وارسالها عبر رسالة واتساب على الرقم التالي  81/348838.
تقوم الشركة بتسليم الدواء للصيدلية المحددة او عبر الكرنتينا اذا كان المريض غير مضمون او عبر مراكز الدواء الموزعه بالمراكز  
تستغرق هذه العملية تقريبا ٥ ايام عمل بدء من وقت تسليم المستندات المتعلقة بالمريض لجانب وزارة الصحة العامة
 
دواء من الهبة المقدمة بشكل استثنائي لفترة ثلاثة اشهر :  Humira
الحصول على رقم صحي موحد
التوجه لوزارة الصحه الطابق الرابع لاعطائها المستنداتت التاليه :
  1. رقم الصحي الموحد
  2. صورة عن الهويه
  3. تقرير طبي مفصل من الطبيب المختص (روماتيزم، جهاز هضمي، العيون و الجلديه )  
  4. وصفه طبيه موحدة ( مع ذكر اسم الدواء والجرعه المسموح فيها شهريا )
  5. فحوصات مخبريه : sgot, sgpt, creatinine, cbc
 
Guidelines for Pharmacy Stock Management Systems Integration with MediTrack System
  • API documentation that is needed by the pharmacy software companies to start the integration with MediTrack are listed below:
Patient UHID
Pharmacy Movements
Pharmacy Sales API
 
  • The test environment base URLs:
To make sure that your Pharmacy Stock Management System is compliant with MediTrack guidelines, below are the primary URLs for trials by software company owners:

Nevertheless, please be aware that we have two API services at MOPH, namely
 /api and /meditrackapi.
You can find these services at the following URLs:
1.    https://meditrack.moph.gov.lb:38440/api
2.    https://meditrack.moph.gov.lb:38440/meditrackapi
It is essential to obtain the token from the same application (same BaseURL)

Patient UHID base URL: https://meditrack.moph.gov.lb:38440/meditrackapi/
Pharmacy Movements base URL: https://meditrack.moph.gov.lb:38440/api/
Pharmacy Sales base URL: https://meditrack.moph.gov.lb:38440/
 
 
Guidelines-Implementation of the 2D BarCode on Pharmaceuticals
In order to ensure the patient’s access to safe drugs, the Ministry of Public Health has adopted the two-dimensional (2D) barcode as a unified identification number on the package of the pharmaceutical products. The 2D barcode will help trace these products within the supply chain, from manufacturing, to storage, distribution and receipt of drugs by patients.

It has therefore become necessary to develop this manual designed to ensure the adoption of the necessary standards to include the barcode on drugs and help seize smuggled and counterfeit drugs in the Lebanese market.

Guidelines-Implementation of the 2D BarCode on Pharmaceuticals-Edition2-2020 (update related to the barcode reader configuration)

Director General Letter 2020/4/15753 in 22/5/2020
 
Pharmaceutical Companies Connected to "Meditrack System"
 
Laws And Regulations
 
 
Presentations
 
Contacts Us
Phone Number:
01/830300 Ext:292- 268- 265

Emails:
ehealth@moph.gov.lb
drugsbarcode@moph.gov.lb
 
Media

    1
    ...
ATC Name B/G Ingredients Dosage Form Price
A02BC01 DIGCAP G Omeprazole - 20mg 20mg Capsule 593,850 L.L
J01FF01 DALACIN-C B Clindamycin HCl - 150mg 150mg Capsule 287,582 L.L
J01FF01 DALACIN-C B Clindamycin HCl - 300mg 300mg Capsule 478,408 L.L
J01FF01 DANALLI G Clindamycin HCl - 300mg 300mg Capsule 267,425 L.L
A11CC05 D-VITAL G Vitamin D3 - 10,000IU 10,000IU Capsule 561,342 L.L
B02BX01 DICYNONE B Etamsylate - 500mg 500mg Capsule 1,311,590 L.L
A11CC05 D-ESTER G Vitamin D3 - 50000IU 50000IU Capsule 1,187,701 L.L
C05BX01 DOXIUM B Calcium dobesilate - 500mg 500mg Capsule 2,151,492 L.L
G04CA52 DUTASTERIDE/TAMSULOSINE ARROW G Tamsulosin HCl - 0.4mg, Dutasteride - 0.5mg Capsule 1,337,123 L.L
C05BX01 DOXIUM B Calcium dobesilate - 500mg 500mg Capsule 1,323,685 L.L
G04CB02 DUTASTERIDE ARROW LAB G Dutasteride - 0.5mg 0.5mg Capsule 1,166,455 L.L
M01AE01 DOLORAZ 400 G Ibuprofen - 400mg 400mg Capsule 362,837 L.L
A03AA04 DUSPATALIN RETARD B Mebeverine HCl - 200mg 200mg Capsule 836,214 L.L
N06AA12 DOXEPIN HCl G Doxepin (HCl) - 10mg 10mg Capsule 712,876 L.L
N06AA12 DOXEPIN HCl G Doxepin (HCl) - 50mg 50mg Capsule 965,007 L.L
J02AC01 DIFLUCAN B Fluconazole - 50mg 50mg Capsule 796,899 L.L
J02AC01 DIFLUCAN B Fluconazole - 150mg 150mg Capsule 286,238 L.L
J01AA02 DOXYLAG G Doxycycline (HCl) - 100mg 100mg Capsule 174,700 L.L
B01AC18 DISGREN B Triflusal - 300mg 300mg Capsule 555,007 L.L
A02BC06 DEXILANT B Dexlansoprazole - 30mg 30mg Capsule, delayed release 1,595,141 L.L
A02BC06 DEXILANT B Dexlansoprazole - 30mg 30mg Capsule, delayed release 1,595,141 L.L
A02BC06 DEXILANT B Dexlansoprazole - 60mg 60mg Capsule, delayed release 2,375,914 L.L
A02BC06 DEXILANT B Dexlansoprazole - 60mg 60mg Capsule, delayed release 2,375,914 L.L
N06AX21 DULOXA 60 G Duloxetine HCl - 60mg 60mg Capsule, delayed release 831,903 L.L
N06AX21 DULOXA 30 G Duloxetine HCl - 30mg 30mg Capsule, delayed release 716,716 L.L
M01AB05 DIVIDO 75MG B Diclofenac sodium - 75mg 75mg Capsule, dual release 372,244 L.L
N06AX16 DEFAXINE G Venlafaxine (HCl) - 75mg 75mg Capsule, extended release 724,395 L.L
N06AX21 DULOXETINE BIOGARAN G Duloxetine HCl - 60mg 60mg Capsule, gastro-resistant 573,821 L.L
N06AX21 DULOXETINE BIOGARAN G Duloxetine HCl - 30mg 30mg Capsule, gastro-resistant 573,821 L.L
A11CC05 D-VITAL G Vitamin D3 - 50,000IU 50,000IU Capsule, hard 712,620 L.L
    1
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2024